KANSAS CITY, Kan., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...
In the randomized, double-blind, pediatric and adolescent, placebo-controlled study, CTx-1301 delivered rapid onset of effect ...
Herpes Simplex Encephalitis: Flair axial MRIs. Note the abnormal (bright) signal in both temporal lobes (left image). Also note the involvement of the insula on the right side (middle image) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback